Results for
""Thionucleotides""[mesh_terms]

Phosphorothioate nucleotides and oligonucleotides - recent progress in synthesis and application.

Maria Koziołkiewicz, Piotr Guga

Chemistry & biodiversity 2012;8(9):1642-81

Progress in thioaptamer development.

David G Gorenstein, Xianbin Yang

Current drug targets 2005;5(8):705-15

Oblimersen sodium (Genasense bcl-2 antisense oligonucleotide): a rational therapeutic to enhance apoptosis in therapy of lung cancer.

Roy S Herbst, Stanley R Frankel

Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(12 Pt 2):4245s-4248s

Thiopurine therapies: problems, complexities, and progress with monitoring thioguanine nucleotides.

Timothy H J Florin, John A Duley

Therapeutic drug monitoring 2006;27(5):647-54

Reversibility, equilibration, and fidelity of strand exchange reaction between short oligonucleotides promoted by RecA protein from escherichia coli and human Rad51 and Dmc1 proteins.

Alexander A Volodin, Tatiana N Bocharova, Elena A Smirnova, R Daniel Camerini-Otero

The Journal of biological chemistry 2009;284(3):1495-504

Targeting anti-apoptotic genes upregulated by androgen withdrawal using antisense oligonucleotides to enhance androgen- and chemo-sensitivity in prostate cancer.

Martin E Gleave, Toby Zellweger, Kim Chi, Hideaki Miyake, Satoshi Kiyama, Laura July, Simon Leung

Investigational new drugs 2002;20(2):145-58

The use of manganese as a probe for elucidating the role of magnesium ions in ribozymes.

A L Feig

Metal ions in biological systems 2000;37():157-82

A short fragment of 23S rRNA containing the binding sites for two ribosomal proteins, L24 and L4, is a key element for rRNA folding during early assembly.

K H Nierhaus, U Stelzl

RNA (New York, N.Y.) 2001;7(4):598-609

Oxidatively-generated damage to DNA and proteins mediated by photosensitized UVA.

Peter Karran, Melisa Guven, Reto Brem

Free radical biology & medicine 2018;107():101-109

Early results of a phase I trial of oblimersen sodium for relapsed or refractory Waldenstrom's macroglobulinemia.

Morie A Gertz, Susan M Geyer, Ashraf Badros, Brad S Kahl, Charles Erlichman

Clinical lymphoma 2005;5(4):282-4

A phase I trial of a Bcl-2 antisense (G3139) and weekly docetaxel in patients with advanced breast cancer and other solid tumors.

J Marshall, H Chen, D Yang, M Figueira, K B Bouker, Y Ling, M Lippman, S R Frankel, D F Hayes

Annals of oncology : official journal of the European Society for Medical Oncology 2004;15(8):1274-83

A randomized controlled clinical trial of intravitreous fomivirsen for treatment of newly diagnosed peripheral cytomegalovirus retinitis in patients with AIDS.

American journal of ophthalmology 2002;133(4):467-74

A phase I, pharmacokinetic and biologic correlative study of oblimersen sodium (Genasense, G3139) and irinotecan in patients with metastatic colorectal cancer.

M M Mita, L Ochoa, E K Rowinsky, J Kuhn, G Schwartz, L A Hammond, A Patnaik, I-T Yeh, E Izbicka, K Berg, A W Tolcher

Annals of oncology : official journal of the European Society for Medical Oncology 2007;17(2):313-21

Docetaxel plus oblimersen sodium (Bcl-2 antisense oligonucleotide): an EORTC multicenter, randomized phase II study in patients with castration-resistant prostate cancer.

C N Sternberg, H Dumez, H Van Poppel, I Skoneczna, A Sella, G Daugaard, T Gil, J Graham, P Carpentier, F Calabro, L Collette, D Lacombe

Annals of oncology : official journal of the European Society for Medical Oncology 2009;20(7):1264-9

Monitoring protein-ligand interactions by time-resolved FTIR difference spectroscopy.

Klaus Gerwert, Carsten Kötting

Methods in molecular biology (Clifton, N.J.) 2013;1008():299-323